Remdesivir Shows Modest Benefits in Coronavirus Trial. Coronavirus (2019-nCoV), Remdesivir (Drug), Gilead Sciences Inc, Clinical Trials, Fauci, Anthony S, National Institute of Allergy and Infectious Diseases, your-feed-science